Nonsurgical factors affecting symptomatic outcomes of antireflux surgery

Diseases of the Esophagus

Volumn 19, Issue 1, 2006, Pages 1-4

  Velanovich, Vic ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Antireflux surgery; Personality; Psychoemotional disorders

Indexed keywords

ANTIREFLUX OPERATION; CHRONIC PAIN; CULTURAL FACTOR; EMOTIONAL DISORDER; ENTEROPATHY; ESOPHAGUS DISEASE; ESOPHAGUS FUNCTION DISORDER; GASTROESOPHAGEAL REFLUX; HUMAN; MENTAL DISEASE; NOCICEPTION; PATHOPHYSIOLOGY; PERSONALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ANXIETY DISORDERS; CULTURE; ESOPHAGEAL DISEASES; GASTROESOPHAGEAL REFLUX; HUMANS; INTESTINAL DISEASES; MENTAL DISORDERS; PAIN, POSTOPERATIVE; PHARMACEUTICAL PREPARATIONS; POSTOPERATIVE COMPLICATIONS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 33645986127     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00528.x     Document Type: Review

References (41)

1. Soper N J, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg 1999; 229: 669-77.
2. Hunter J G. Approach and management of patients with recurrent gastroesophageal reflux disease. J Gastrointest Surg 2001; 5: 451-7.
3. Hinder R A, Kingler P J, Perdikis G, Smith S L. Management of the failed antireflux operation. Surg Clin North Am 1997; 77: 1083-98.
4. Lord R V N, Kaminski A, Oberg S et al. Absence of gastroesophageal reflux disease in a majority of patients taking acid suppression medications after Nissen fundoplication. J Gastrointest Surg 2002; 6: 3-10.
5. Khajanchee Y S, O'Rourke R W, Lockhart B, Patterson E J, Hansen P D, Swanstrom L L. Postoperative symptoms and failure after antireflux surgery. Arch Surg 2002; 137: 1008-14.
6. Velanovich V. Medication usage and additional esophageal procedures after antireflux surgery. Surg Laparosc Endosc 2003; 13: 161-4.
7. Mittall R, Holloway R, Pengini R, Blackshaw L, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology 1995; 109: 601-10.
8. Hinder R. Gastroesophageal reflux disease. In: Bell R H, Rikkers L F, Mulholland M W, eds. Digestive Tract Surgery: A Text and Atlas. Philadelphia: Lippincott-Raven Publishers 1996: 3-26.
9. Holloway R, Wyman J, Dent J. Failure of transient lower esophageal sphincter relaxation in response to gastric distension in patients with achalasia: Evidence for neural mediation of transient lower esophageal sphincter relaxations. Gut 1989; 30: 762-7.
10. Blom D, Peters J H, DeMeester T R et al. Physiologic mechanism and preoperative prediction of new-onset dysphagia after laparoscopic Nissen fundoplication. J Gastrointest Surg 2002; 6: 22-8.
11. Winslow E R, Frisella M M, Soper N J, Clouse R E, Klingensmith M E. Patients with upright reflux have less favorable postoperative outcomes after laparoscopic antireflux surgery than those with supine reflux. J Gastrointest Surg 2002; 6: 819-30.
12. Velanovich V, Mahatme A. Effects of manometrically discovered nonspecific motility disorders of the esophagus on the outcomes of antireflux surgery. J Gastrointest Surg 2004; 8: 335-41.
13. Swanstrom L L. Management of patients with gastroesophageal reflux disease and esophageal or gastric dysmotility. J Gastrointest Surg 2001; 5: 448-50.
14. Fields H L, Martin J B. Pain: Pathophysiology and management. In: Braunwold E, Fauci A S, Kasper D L, Hauser S L, Longo D L, Jameson J L, eds. Harrison's Principles of Internal Medicine, 15th edn. New York: McGraw-Hill 2001: 55-60.
15. Reus V I. Mental disorders. In: Braunwold E, Fauci A S, Kasper D L, Hauser S L, Longo D L, Jameson J L, eds. Harrison's Principles of Internal Medicine, 15th edn. New York: McGraw-Hill 2001: 2542-57.
16. Gilliland B C. Relapsing polychondritis and other arthritidies. In: Braunwold E, Fauci A S, Kasper D L, Hauser S L, Longo D L, Jameson J L, eds. Harrison's Principles of Internal Medicine, 15th edn. New York: McGraw-Hill 2001: 2005-16.
17. Kamolz T, Velanovich V. Psychological and emotional aspects of gastroesophageal reflux disease. Dis Esophagus 2002; 15: 199-203.
18. Velanovich V, Ben-Menachem T, Kamolz T. Objective physiologic measurements of gastroesophageal reflux disease in patients with anxiety and depression disorders. Presented at the 2003 Annual Meeting of the American Gastroenterological Association, Orlando, USA, May 19, 2003.
19. Cassisi J E, Umeda M, Deisinger J A, Sheffer C, Lofland K R, Jackson C. Patterns of pain descriptor usage in African Americans and European Americans with chronic pain. Cultural Diversity Ethnic Minority Pscyhol 2004; 10: 81-9.
20. Davidhizar R, Giger J N. A review of the literature on care of clients in pain who are culturally diverse. Int Nurs Rev 2004; 51: 47-55.
21. Fainsinger R L, Nunez-Olarte J M, Demoissac D M. The cultural differences in preceived value of disclosure and cognition: Spain and Canada. J Palliat Care 2003; 19: 43-8.
22. Alberque C, Eytan A. Chronic pain presenting as major depression in a cross-cultural setting. Int J Psych Med 2001; 31: 73-6.
23. Vega K J. Gastroesophageal reflux disease in minority America. Pract Gastroenterol 2002; 26: 35-45.
24. Armstrong D. Reflux disease and Barrett's oesophagus. Endoscopy 1994; 26: 9-19.
25. Segal I. The gastro-oesophageal reflux disease complex in sub-Saharan Africa. Eur J Cancer Prev 2001; 10: 209-12.
26. Haithcock B, Velanovich V. Comparison of antireflux surgery among ethnicity. J Natl Assoc Med 2004; 96: 535-41.
27. Velanovich V, Kamolz T, Pointner R, Contini S. Qualitative analysis of the expectations of patients of different nationalities of antireflux surgery. Dis Esophagus in press.
28. Watson D I, Chan A S L, Myers J C, Jamieson G G. Illness behavior influences the outcome of laparoscopic antireflux surgery. J Am Coll Surg 1997; 184: 44-8.
29. Velanovich V. The effect of chronic pain syndromes and psychoemotional disorders on symptomatic and quality-of-life outcomes of antireflux surgery. J Gastrointest Surg 2003; 7: 53-8.
30. Velanovich V. Using quality-of-life measurements to predict patient satisfaction outcomes for antireflux surgery. Arch Surg 2004; 139: 621-6.
31. Kamolz T, Bammer T, Wykypiel H Jr, Pointner R. Coping with stress and personality in patients with or without stress-related symptoms in gastroesophageal reflux disease. Z Gastroenterol 1999; 37: 265-70.
32. Kamolz T, Granderath FA, Bammer T, Pointner R. Psychological intervention influences the outcome of laparoscopic antireflux surgery in patient with stress-related symptoms of gastroesophageal reflux disease. Scand J Gastroenterol 2001; 36: 800-5.
33. Clouse R E, Richter J E, Heading R C, Janssen J, Wilson J A. Functional esophageal disorders. Gut 1999; 45 (Suppl II): II31-6.
34. Mertz H R. Overview of functional gastrointestinal disorders: Dysfunction of the brain-gut axis. Gastroenterol Clin N Am 2003; 32: 463-76.
35. Budavari A I, Olden K W. Psychological aspects of functional gastrointestinal disorders. Gastroenterol Clin N Am 2003; 32: 477-506.
36. Gorelick A B, Koshy S S, Hooper F G et al. Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 1998; 275: G460-6.
37. Peghini P I, Katz P O, Castell D O. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998; 42: 807-10.
38. Prakash C, Clouse R E. Long-term outcome of tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999; 44: 2373-9.
39. Clouse R E. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994; 39: 2352-63.
40. Velanovich V. Tricyclic antidepressants in the treatment of postoperative antireflux surgery symptoms. Dig Liv Dis 2005; 37: 458.
41. Barsky A J, Saintfort R, Rogers M P, Borus J F. Nonspecific medication side effects and the nocebo phenomenon. JAMA 2002; 287: 622-7.